Citation:Hainsworth JD, Spigel DR, Farley C, Shipley DL, Bearden JD, Gandhi J, et al 2007

From Cancer Guidelines Wiki

Citation


Hainsworth JD, Spigel DR, Farley C, Shipley DL, Bearden JD, Gandhi J, et al. Weekly docetaxel versus docetaxel/gemcitabine in the treatment of elderly or poor performance status patients with advanced nonsmall cell lung cancer: a randomized phase 3 trial of the Minnie Pearl Cancer Research Network. Cancer 2007 Nov 1;110(9):2027-34 Available from: http://www.ncbi.nlm.nih.gov/pubmed/17823908.



Critical appraisals

Critical appraisal linkClinical questionAssigned toStatus
Hainsworth JD, Spigel DR, Farley C, Shipley DL, Bearden JD, Gandhi J, et al 2007What is the optimal systemic therapy for stage IV inoperable NSCLC?Assoc. Prof. Nick Pavlakiscompleted
Hainsworth JD, Spigel DR, Farley C, Shipley DL, Bearden JD, Gandhi J, et al 2007 2What is the optimal systemic therapy regimen for patients with poor performance status for treatment of stage IV inoperable NSCLC?Assoc. Prof. Nick Pavlakiscompleted
Hainsworth JD, Spigel DR, Farley C, Shipley DL, Bearden JD, Gandhi J, et al 2007 3What is the optimal systemic therapy regimen for elderly patients for treatment of stage IV inoperable NSCLC?Assoc. Prof. Nick Pavlakiscompleted

Compare quality appraisals for each clinical question

  • [[Clinical question:What is the optimal systemic therapy for stage IV inoperable NSCLC?|
    Invalid title «<span class="smw-format list-format "><span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:What is the optimal systemic therapy for stage IV inoperable NSCLC?</span></span></span>»
    ]] (compare critical appraisals)
  • [[Clinical question:What is the optimal systemic therapy regimen for patients with poor performance status for treatment of stage IV inoperable NSCLC?|
    Invalid title «<span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:What is the optimal systemic therapy regimen for patients with poor performance status for treatment of stage IV inoperable NSCLC?</span></span></span>»
    ]] (compare critical appraisals)
  • [[Clinical question:What is the optimal systemic therapy regimen for elderly patients for treatment of stage IV inoperable NSCLC?|
    Invalid title «<span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:What is the optimal systemic therapy regimen for elderly patients for treatment of stage IV inoperable NSCLC?</span></span></span></span>»
    ]] (compare critical appraisals)

Cited by

  1. What is the optimal systemic therapy for stage IV inoperable NSCLC?
  2. What is the optimal systemic therapy regimen for elderly patients for treatment of stage IV inoperable NSCLC?
Retrieved from "https://wiki.cancer.org.au/australiawiki/index.php?title=Citation:Hainsworth_JD,_Spigel_DR,_Farley_C,_Shipley_DL,_Bearden_JD,_Gandhi_J,_et_al_2007&oldid=21668"